• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    National HealthCare Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    5/13/25 4:11:59 PM ET
    $NHC
    Hospital/Nursing Management
    Health Care
    Get the next $NHC alert in real time by email
    nhc20250512_8k.htm
    false 0001047335 0001047335 2025-05-08 2025-05-08
     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     

     
    FORM 8-K
     
    CURRENT REPORT
     
    Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
     
    Date of Report (Date of earliest event reported): May 13, 2025 (May 8, 2025)
     

     
    NATIONAL HEALTHCARE CORPORATION
    (Exact name of registrant as specified in its charter)
     

     
    Delaware
    (State or other jurisdiction of incorporation)
    001-13489
    (Commission File Number)
    52-2057472
    (I.R.S. Employer Identification No.)
         
    100 Vine Street
    Murfreesboro, Tennessee
    (Address of Principal Executive Offices)
     
    37130
    (Zip Code)
     
     
    Registrant’s telephone number, including area code: (615) 890-2020
     
     
    Not Applicable
    (Former name or former address, if changed since last report)
     

     
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
     
    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))
     
    Securities registered pursuant to Section 12(b) of the Act:
     
    Title of each class
    Trading Symbol(s)
    Name of each exchange on which registered
    Common Stock, $0.1 par value
    NHC
    NYSE American
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
     
    Emerging growth company     ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐
     
     

     
     
    ITEM 5.07.     SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
     
    The Annual Meeting of Shareholders (the “Annual Meeting”) of National HealthCare Corporation (the “Company”) was held on May 8, 2025. As of the record date, March 14, 2025, there were a total of 15,461,829 shares of Common Stock outstanding and entitled to vote at the Annual Meeting. At the Annual Meeting, 12,996,474 shares of Common Stock were represented in person or by proxy; therefore, a quorum was present. The following is a summary of the matters voted upon by the Company's shareholders at the Annual Meeting and the related results:
     
    1.
    The Re-election of Stephen F. Flatt, Richard F. LaRoche, and Sandra Y. Trail as directors to each hold office for a three (3) year term and until their successors have been duly elected and qualified:
     
       
    For
       
    Against
       
    Abstain
     
    Stephen F. Flatt
     
    12,891,818
       
    94,786
       
    9,870
     
    Richard F. LaRoche
     
    9,670,492
       
    3,319,813
       
    6,169
     
    Sandra Y. Trail
     
    11,718,150
       
    1,265,760
       
    12,564
     
     
    2.
    To consider an advisory vote on the compensation of our Named Executive Officers.
     
    For
     
    Against
     
    Abstain
    12,498,222
     
    477,555
     
    20,697
     
     
    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
    Date:     May 13, 2025
     
    NATIONAL HEALTHCARE CORPORATION
     
     
     
    By: /s/Josh A. McCreary
    Name: Josh A. McCreary
    Title: Senior Vice President, General Counsel, and Secretary
     
     
    Get the next $NHC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NHC

    DatePrice TargetRatingAnalyst
    More analyst ratings